Ticker Short Interest

CRSP Short Interest Intelligence

Crispr Therapeutics AG positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Neutral

Neutral

Covering Rally

CRSP is classified as Neutral. Latest reported short interest is 20.4M shares; short interest changed -23.2%, price moved +10.3% since the previous report, short interest is in the 14th percentile, and days to cover is in the 14th percentile. Trend context is constructive.

Setup Score45/100Neutral
Reported Short Interest20.4M-23.2% vs prior report
Days To Cover11.6514.29 percentile
Price Reaction+10.3%since previous short report
Squeeze Pressure36crowding, trend, and pressure
Bearish Conviction6shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

36

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

6

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

14

Latest short interest is 20.4M shares and days to cover is 11.65.

Divergence

0

Short interest fell while price rose. The bearish trade appears to be unwinding into strength.

Report History

CRSP Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 20397833 26572400 -23.2% 11.65 1750460
15 Jun 2026 26572400 21672640 22.6% 16.35 1625617
29 May 2026 21672640 27293997 -20.6% 12.29 1763869
15 May 2026 27293997 22484150 21.4% 16.54 1650520
30 Apr 2026 22484150 22752661 -1.2% 11.91 1887089
15 Apr 2026 22752661 22618060 0.6% 15.30 1487383
31 Mar 2026 22618060 21686413 4.3% 13.23 1709227

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.